Anthem Biosciences IPO

NSELot: 26

LISTEDMAINBOARD
Issue Price570
Listing640.68
Current635
Price Band
540 - ₹570
Lot Size
26
Issue Size
₹3395 Cr
GMP
0
Subscription
0.77x

IPO Schedule

1
Open
14 Jul
2
Close
16 Jul
3
Allotment
-
4
Listing
21 Jul

About Anthem Biosciences

Anthem Biosciences is a contract research and manufacturing services (CRAMS) provider focused on the pharmaceutical and biotechnology industries. They offer a range of services, including drug discovery, development, and manufacturing, catering to both domestic and international clients.

Subscription Status

QIB
0.39x
NII
1.64x
Retail
0.62x
CategoryDay 3Day 2Day 1
QIB192.80x0.62x0.39x
NII44.70x10.26x1.64x
Retail5.98x2.21x0.62x
Total67.42x3.48x0.77x

Risk Factors

Dependence on key clients, with a significant portion of revenue derived from a limited number of customers.
Exposure to regulatory risks and compliance requirements in the pharmaceutical industry.
Intense competition from other CRAMS providers, both domestic and international.